AbbVie Targets Hetero Over Generic Norvir Plans
AbbVie Inc. on Wednesday hit Hetero USA Inc. in Delaware federal court with allegations that the generics maker infringes several patents with its planned generic version of HIV treatment Norvir....To view the full article, register now.
Already a subscriber? Click here to view full article